We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -3.85% | 1.25 | 1.10 | 1.40 | 1.30 | 1.25 | 1.30 | 284,138 | 10:30:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.57 | 1.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2018 12:46 | Thanks for the response davet. I have a small punt in here and believe there is an opportunity for PYC. Time will tell. | rolaw1 | |
12/9/2018 12:20 | If you think this is old tech??? why did MERCK invest £500,000 LOL You lot talk through your end passage. More contracts to follow. | fqr714bhp | |
12/9/2018 11:58 | One and 2, 3 isn't quite right unless you think stating facts is bashing. | davevt | |
12/9/2018 11:38 | What is your interest here davet? Are you trying to protect the innocent investors from making careless mistakes or you think that The Stigologist is completely and utterly wrong (on everything) or are you just out there to bash the hell out of the PYC? I am curious. | rolaw1 | |
12/9/2018 11:12 | Howdlep, it's not a good thing that they are 'ahead of market expectations' and still making a loss is it. | davevt | |
12/9/2018 11:09 | How can they be a 'serious AI Machine Learning player' when all they do is use 15 year old tech to tell pharmas how much medicine to give patients in trials and how often to give it to them. That's all they do, dosage modelling. The tech is so old the patents expired a couple of years ago. Stig has no clue what this company does, hence why it has turnovers lower than your local pub, let alone make a profit. | davevt | |
12/9/2018 11:05 | The company value it at 4p, the placing was at 4p, the CEO sold a load of personal shares at 8p. Stig the dreamer still thinks it's worth 100p. The company, investors, ceo and market disagree lol. | davevt | |
12/9/2018 10:40 | If you check long term chart you'll see PYC has often had moonshoots to 100p+ | the stigologist | |
12/9/2018 10:39 | Should be 10-20p right now 50p probable target if they get Glaxo or A.N.Other to add to Merck 100p+ possible if they become a serious AI Machine Learning player in a market where Deepmind GRAIL inc involved | the stigologist | |
12/9/2018 10:32 | Thank you guys. 20% profit for moi in 2 months. Good luck for the future. May be back later. | jungmana | |
12/9/2018 10:08 | They have confirmed that results will be ahead of market expectations, with increased revenues and a vastly reduced loss. MM's react to demand and price is reflective of that demand. Contrary to what others will have you believe, sentiment is changing very positively. I continue to add to my position and hope others maintain or add to their shorts. | howdlep | |
12/9/2018 09:39 | I see this going up to about 6p and then falling back again in line with the overall downward trend and the overall downward spike trend. We will soon see. | cinquepercento | |
12/9/2018 09:36 | For crying out loud how many times have we been here. The MM race up the shares to give the impression something is about to happen. Mug PIs fearful of being left out jump on board. Placing shares are forward sold into the rise and down she goes. Nothing is happening here. | pwhite73 | |
12/9/2018 09:28 | We know what the full year results will be like, they will be at a loss, like every other year. They have already confirmed this. | davevt | |
12/9/2018 09:01 | 10p by year end is a possible. | blueball | |
12/9/2018 08:59 | I think it is all in anticipation for full year results. I think they were on the 10th October last year. And a sizeable contract to go with that would be great. Would be great to see this at 10p by year end. | fqr714bhp | |
12/9/2018 08:46 | OMG!!!!!! This is lift off. Didn't think it would double digits | spacedust | |
11/9/2018 15:56 | A total and utter punt. But it does look good once it breaks over 5/6p. I've bought some on that fond hope. Though his communication skills can a bit crude, sometimes Stig gets it right, as on AOR. | brucie5 | |
11/9/2018 10:59 | Not enough volume to suggest that. Need another 90% to break even. Wippeeeee | spacedust | |
11/9/2018 10:30 | What is going on here today, up 10% Early final result coming up or contract news? | fqr714bhp | |
11/9/2018 10:04 | Hope so ......for anything even a sustained 1 week PnD would do just fine. | spacedust | |
11/9/2018 09:54 | Glaxo GSK news incoming ? | the stigologist | |
10/9/2018 22:52 | Chart consolidating beautifully for a major moonshoot | the stigologist | |
10/9/2018 10:14 | Also, it's not possible for any of their recent clients to have had a drug finalized and approved in 6 months, impossible. The clients of pyc are using the services for PRE clinical trials, and pyc state it takes them roughly 3 months of modelling for them create the data for the client to use. Then obviously the pre clinical trial has to be run by the client, which can take months if not a year, see if the results were similar to the drug companies manual trials, see if the drug really does work, and then proceed onto more detailed clinical trials, further months/year and repeat. Hence why drugs on average take a couple of years to make it onto market. | davevt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions